Hepatitis C Virus: Biological and Clinical Consequences of Genetic Heterogeneity

References

• Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome. Science 1989; 244: 359–62
   PubMed Web of Science ®Google Scholar
• Barrera J M, Bruguera M, Ercilla M G, Sanchez-Tapias J M, Gil M P, Costa J, et al. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies for hepatitis C virus and surrogate markers. Ann Intern Med 1991; 115: 596–600
   PubMedGoogle Scholar
• Kuo G, Choo Q L, Alter H J, Gitnick G L, Redeker A G, Purcell R H, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4
   PubMed Web of Science ®Google Scholar
• Stevens C E, Taylor P E, Pindyck J, Choo Q L, Bradley D W, Kuo G, et al. Epidemiology of hepatitis C virus: a preliminary study in volunteer blood donors. JAMA 1990; 263: 49–53
   PubMed Web of Science ®Google Scholar
• Sirchia G, Almini D, Bellobuono A, Giovanetti A M, Marconi M, Mercuriali F, et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 1990; 59: 26–9
   PubMedGoogle Scholar
• Van der Poel C L, Reesinck H W, Lelie P N, Leentvaar-Kuypers A, Choo Q L, Kuo G, et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 1989; 2: 297–8
   PubMed Web of Science ®Google Scholar
• Saeed A A, Admawi A J, Al Rasheed A, Fairclough D, Bacchus R, Ring C, et al. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991; 338: 459–60
   PubMed Web of Science ®Google Scholar
• Simmonds P. Variability of Hepatitis virus. Hepatology 1995; 21: 570–83
   PubMed Web of Science ®Google Scholar
• Choo Q L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, et al. Vaccination of chimpanzees against infection by the hepatitis C vims. Proc Natl Acad Sci USA 1994; 91: 1294–8
   PubMed Web of Science ®Google Scholar
• Sherlock D S. Chronic hepatitis C. Dis Mon 1994; 40: 117–96
   PubMed Web of Science ®Google Scholar
• Alter A J, Margolis H S, Krawczynski K, Judson F N, Mares A, Alexander J, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–905
   PubMed Web of Science ®Google Scholar
• Esteban J I, Lopez-Talavera J C, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443–9
   PubMed Web of Science ®Google Scholar
• Kao J H, Tsai S L, Chen P J, Yang P M, Sheu J C, Lai M Y, et al. A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. J Hepatol 1994; 21: 244–9
   PubMedGoogle Scholar
• Davis G L, Balart L A, Schiff E R, Lindsay K, Bodenheimer H C, Perrilo R P, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989; 321: 1501–6
   PubMed Web of Science ®Google Scholar
• Di Bisceglie A M, Goodman Z D, Ishak K G, Hoofnagle J, Melpolder J J, Alter H J. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969–74
   PubMed Web of Science ®Google Scholar
• Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 675–80
   PubMed Web of Science ®Google Scholar
• Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of hepatitis C. Am J Gastroenterol 1993; 88: 240–3
   PubMed Web of Science ®Google Scholar
• Bjoro K, Froland S S, Yun Z, Samdal H H, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607–11
   PubMed Web of Science ®Google Scholar
• Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, Mondelli M U. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994; 84: 2919–22
   PubMed Web of Science ®Google Scholar
• Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomized clinical trials. J Hepatol 1991; 13: 192–9
   Google Scholar
• Di Bisceglie A M, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al. Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506–10
   PubMed Web of Science ®Google Scholar
• Miller R H, Purcell R H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 1990; 87: 2057–61
   PubMed Web of Science ®Google Scholar
• Choo Q L, Richman K H, Han J H, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451–5
   PubMed Web of Science ®Google Scholar
• Tsukiyama-Kohara K, Likuza N, Kohara M, Nomoto A. Internal ribosomal entry site within hepatitis C virus RNA. J Virol 1992; 66: 1476–83
   PubMed Web of Science ®Google Scholar
• Weiner A J, Brauer M J, Rosenblatt J, Richman K H, Tung J, Crawford K, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842–8
   PubMed Web of Science ®Google Scholar
• Houghton M, Weiner A, Han J, Kuo G, Choo Q L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381–8
   PubMed Web of Science ®Google Scholar
• Chambers T J, Weir R C, Grakoui A, McCourt D W, Bazan J F, Fletterick R J, et al. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavage in the viral polyprotein. Proc Natl Acad Sci USA 1990; 87: 8898–902
   PubMed Web of Science ®Google Scholar
• Eckart M R, Selby M, Masiarz F, Lee C, Berger K, Crawford K, et al. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 1993; 192: 399–406
   PubMed Web of Science ®Google Scholar
• Tomei L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 1993; 67: 4017–26
   PubMed Web of Science ®Google Scholar
• Grakoui A, Wychowski C, Lin C, Feinstone S M, Rice C M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993; 67: 1385–95
   PubMed Web of Science ®Google Scholar
• Simmonds P, Alberti A, Alter H J, Bonino F, Bradley D W, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321–4
   PubMed Web of Science ®Google Scholar
• Okamoto H, Sugiyama Y, Okada S, Kurai K, Alahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673–9
   PubMed Web of Science ®Google Scholar
• Murphy D, Willems B, Delage G. Use of the 5′ noncoding region for genotyping hepatitis C virus. J Infect Dis 1994; 169: 473–5
   PubMedGoogle Scholar
• Bukh J, Purcell R H, Miller R H. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide. Proc Natl Acad Sci USA 1993; 90: 8234–8
   PubMed Web of Science ®Google Scholar
• McOmish F, Yap P L, Dow B C, Follet E AC, Seed C, Keller A J, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884–92
   PubMed Web of Science ®Google Scholar
• Steinhauer D A, Holland J J. Rapid evolution of RNA viruses. Ann Rev Microbiol 1987; 41: 409–33
   PubMed Web of Science ®Google Scholar
• Kurokasi M, Enomote N, Marumo F, Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993; 18: 1293–9
   PubMedGoogle Scholar
• Martel M, Esteban J I, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225–9
   PubMedGoogle Scholar
• McOmish F, Chan S W, Dow B C, Gillon J, Frame W D, Crawford R J, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7–13
   PubMedGoogle Scholar
• Kleter G EM, Van Doom U, Brouwer J T, Schalm S W, Heijtink R A, Quint W GV. Sequence analysis of the 5′ untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands. J Clin Microbiol 1994; 32: 306–10
   PubMedGoogle Scholar
• Qu D, Hantz O, Gouy M, Vitvitski L, Li J, Berby F, Tong S, et al. Heterogeneity of hepatitis C virus genotypes in France. J Gen Virol 1994; 75: 1063–70
   PubMedGoogle Scholar
• Nousbaum J B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, collaborative study group. Hepatitis C virus type 1b (IE) infection in France and Italy. Ann Intern Med 1995; 122: 161–8
   PubMed Web of Science ®Google Scholar
• Dusheiko G, Scmilovitz-Weiss H, Brown D, McOmish F, Yap P L, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13–8
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-βT. Hepatology 1993; 18: 1319–25
   PubMedGoogle Scholar
• Greene W K, Cheong M K, Ng V, Yap K W. Prevalence of hepatitis C virus sequence variants in South-East Asia. J Gen Virol 1995; 76: 211–5
   PubMedGoogle Scholar
• Tokita H, Okamoto H, Tsuda F, Song P, Nakata S, Chosa T. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91: 11022–6
   PubMedGoogle Scholar
• Farci P, Alter H J, Wong D, Miller R H, Shih J W, Jett B, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325: 98–104
   PubMed Web of Science ®Google Scholar
• Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Olikoshi S, Shimotolmo K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220–8
   PubMedGoogle Scholar
• Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107–23
   PubMed Web of Science ®Google Scholar
• Ogata N, Alter H J, Miller R H, Purcell R H. Nucleotide sequence and mutation rate of the H starin of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392–6
   PubMed Web of Science ®Google Scholar
• Enomoto N, Sakamoto N, Kurosaki M, Marumo F, Sato C. The hypervariable region of the HCV genome changes sequentially during the progression of acute HCV infection to chronich hepatitis. J Hepatol 1993; 17: 415–22
   PubMedGoogle Scholar
• Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, et al. Genetic drift in hypervariable region 1 of viral genome in persistent hepatitis C virus infection. J Virol 1994; 68: 4776–84
   PubMedGoogle Scholar
• Zonaro A, Ravaggi A, Puoti M, Kremsdorf D, Alertini A, Cariani E. Differential pattern of sequence heterogeneity in the hepatitis C virus El and E2/NS1 proteins. J Hepatol 1994; 21: 858–65
   PubMedGoogle Scholar
• Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T, et al. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C 100–3 protein. J Clin Invest 1993; 92: 1529–33
   PubMedGoogle Scholar
• Yuki N, Hayashi N, Hagiwara H, Takehara T, Oshita M, Kasahara A, et al. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay. J Hepatol 1993; 17: 170–4
   PubMedGoogle Scholar
• Wang Y, Tao Q M, Zhao H Y, Tsuda F, Nagayama R, Yamamoto K, et al. Hepatits C virus RNA and antibodies among blood donors in Beijing. J Hepatol 1994; 21: 634–40
   PubMedGoogle Scholar
• Simmonds P, Rose K A, Graham S, et al. Mapping of serotype-specific, immunodominant epitopes in the NS4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infection with HCV types 1, 2, and 3. J Clin Microbiol 1993; 31: 1493–503
   PubMed Web of Science ®Google Scholar
• Tanaka E, Kiyosawa K, Matsumoto A, Odeyama T, Urushihara A, Suzuki T, et al. Prevalence of hepatitis C virus with different genotypes determined by a group-specific antibody assay in Japanese patients with chronic liver diseases due to hepatitis C virus infection. Jpn J Med Sci Biol 1994; 47: 47–57
   PubMedGoogle Scholar
• Wolff C, Schlüter K, Prohaska W, Kleesiek K. Improved detection of hepatitis C virus RNA by reverse transcription and polymerase chain reaction. Eur J Clin Chem Clin Biochem 1992; 30: 717–27
   PubMedGoogle Scholar
• Cha T A, Kolberg J, Irvine B, Stempien M, Beall E, Yano M, et al. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol 1991; 29: 2528–35
   PubMed Web of Science ®Google Scholar
• Chan S W, McOmish F, Holmes E C, Dow B, Peutherer J F, Folleff E, et al. Analysis of new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131–41
   PubMed Web of Science ®Google Scholar
• Simmonds P, McOmish F, Yap P L, Chan S W, Lin C K, Dusheiko G, et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661–8
   PubMedGoogle Scholar
• Kukh J, Purcell R H, Miller R H. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992; 89: 4942–6
   PubMedGoogle Scholar
• Xu L Z, Martinot-Peignoux M, Marcellin P, Benhamou J P, Larzul D. Lack of polymerase chain reaction amplification in the 5′ region of a hepatitis C virus isolate. J Infect Dis 1992; 165: 1164–5
   PubMedGoogle Scholar
• Cha T A, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci 1992; 89: 7144–8
   PubMed Web of Science ®Google Scholar
• Widell A, Shev S, Månsson, Zhang Y Y, Foberg U, Norkrans G, et al. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol 1994; 44: 272–9
   PubMed Web of Science ®Google Scholar
• Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285–90
   PubMed Web of Science ®Google Scholar
• Pol S, Thiers V, Nousbaum J B, Legendre C, Berthelot P, Kreis H, et al. Changing distribution of HCV genotypes in Europe in the last decades [abstract]. J Hepatol 1994; 21: S13
   Google Scholar
• Qu D, Li J S, Vitvitski L, Mechai S, Berby F, Tong S P, et al. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type IE. J Hepatol 1994; 21: 70–5
   PubMedGoogle Scholar
• Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C genomes. J Hepatol 1992; 14: 35–40
   PubMed Web of Science ®Google Scholar
• Pol S, Thiers V, Nousbaum J B, Legendre C, Berthelot P, Kreis H, et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995; 108: 581–3
   PubMed Web of Science ®Google Scholar
• Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotype of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088–96
   PubMed Web of Science ®Google Scholar
• Gerotto M, Pontisso P, Giostra F, Francesconi R, Muratori L, Ballardini G, et al. Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol 1994; 21: 273–6
   PubMedGoogle Scholar
• Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy [letter]. N Engl J Med 1994; 330: 143
   PubMed Web of Science ®Google Scholar
• Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, et al. Genotypes and liters of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299–305
   PubMed Web of Science ®Google Scholar
• Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, et al. Factors predictive of response to interferon-therapy in hepatitis C infection. Hepatology 1994; 19: 1088–194
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–9
   PubMed Web of Science ®Google Scholar
• Piccino F, Felaco F M, Aprea L, Messina V, Pasquale G, Sagnelli E. Non-responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus. Arch Virol 1993; Suppl 8:257: 63
   Google Scholar
• Lau J YN, Davis G L, Kniffen J, Qian K P, Urdea M S, Chan C S, et al. Signiflcane of serum hepatitis C virus RNA levels on chronic hepatitis C. Lancet 1993; 341: 1501–4
   PubMed Web of Science ®Google Scholar
• Grottola A, Buttafoco P, Ferretti I, Rebecchi A M, Zoboli P, Merighi A L, et al. Selection of more pathogenic HCV genotype II during long-term follow-up of IFN-treated patients. AASLD abstracts, no 283. Hepatology 1994; 20: 167A
   Google Scholar
• Weiner A J, Geysen H M, Christopherson C, Hall J E, Mason T J, Saracco G, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468–472
   PubMed Web of Science ®Google Scholar
• Farci P, Alter H J, Govindarajan S, Wong D C, Engle R, Lesniewski R R, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135–40
   PubMed Web of Science ®Google Scholar
• Prince A M, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspé G. Immunity in hepatitis C infection. J Infect Dis 1992; 165: 438–43
   PubMed Web of Science ®Google Scholar
• Farci P, Alter H J, Wong D C, Miller R H, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994; 91: 779–6
   Google Scholar
• Erickson A L, Houghton M, Choo Q L, Weiner A J, Ralston R, Muchmore E, et al. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis. J Immunol 1993; 151: 4189–99
   PubMed Web of Science ®Google Scholar
• Ulmer J B, Donnelly J J, Parker S E, Rhodes G H, Feigner P L, Dwarki V J, et al. Gene transfer as a new mode of vaccination: implications for HCV. Hepatology 1993; 18: 696–702
   PubMedGoogle Scholar